Dr. Syam P. Gaddam, MD

Dr. Gaddam practices at Digestive and Liver Disease Specialists a Medical Group Inc in Anaheim, California.

Dr. Gaddam's NPI, 1275510711, was assigned on December 27, 2005. Dr. Gaddam's California license number on file is A50714.

Dr. Gaddam's primary practice is Digestive and Liver Disease Specialists a Medical Group Inc, at 1771 W Romneya Dr, Anaheim, CA 92801 in Orange County. The practice phone is (714) 758-0403.

Dr. Gaddam's primary practice is Digestive and Liver Disease Specialists a Medical Group Inc in Anaheim, California. Dr. Gaddam is also affiliated with AHMC Anaheim Regional Medical Center. The medical group on file is Digestive & Liver Disease Specialists. Dmand AI also links Dr. Gaddam to 1 more hospital, 2 group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaddam practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gaddam's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gaddam is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Gaddam's licenses on file in 2 states: California and Michigan.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis and gastroenteritis among the conditions Dr. Gaddam treats.

CMS data shows 1,529 Medicare services from Dr. Gaddam across 12 procedure codes in 2024, for 484 Medicare patients. Medicare paid $134,407 for them.

CMS counts 484 Medicare patients who saw Dr. Gaddam in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 2.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaddam's median patient age at 60, with 57% women.

In 2024, Dr. Gaddam wrote 2,760 Medicare Part D claims for 504 patients. 85% of them were for generic drugs. CMS names the drug for 2,249 of them, across 64 drugs with 11 or more claims each, at $248,231 in total drug cost. In 2023, CMS named 1,910 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gaddam for performance year 2024, reported individually. Dr. Gaddam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 133 procedures of colonoscopy by Dr. Gaddam, more than 86% of the clinicians it reports for that procedure.

CMS Open Payments shows 398 general payments to Dr. Gaddam from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $1,429.

Dr. Gaddam is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.